Table 2.
Comparison of anti-RNP-A, anti-N IgG and neutralizing antibody levels among COVID-19 patients requiring ICU and non-ICU care and RNP-A positive and negative patient cohorts.
Cohort | N | RNP-A (AI) | anti-N IgG (U/mL) | Nab inhibition (%) |
---|---|---|---|---|
ICU | 41 | 1.2 | 1044.0 | 87.1% |
non-ICU | 78 | 0.4 | 192.8 | 58.6% |
p value | 0.0006 | 0.0002 | <0.0001 | |
RNP-A + | 21 | NA | 1609.9 | 83.2% |
RNP-A - | 98 | NA | 234.0 | 63.2% |
p value | NA | <0.0001 | 0.0031 |
t-test, p value < 0.05, significant difference.